EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY 4.0

Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?

Ioanna Dimitriadou iD, Michael Samarinas iD

Reviews in Cardiovascular Medicine · 17.07.2026 · 27 (7)

DOI: 10.31083/rcm52887 ↗

Kurz gefasst

Editorial in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 17.07.2026. Verfasst von Ioanna Dimitriadou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, University of Thessaly, 41500 Larisa, Greece. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Nursing, University of Thessaly, 41500 Larisa, Greece.
  • Urology Department, Aristotle University of Thessaloniki, Papageorgiou General Hospital, 56429 Thessaloniki, Greece.

ORCID-Profile: Ioanna Dimitriadou, Michael Samarinas

Zitieren

APA

Dimitriadou, I., & Samarinas, M. (2026). Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?. Reviews in Cardiovascular Medicine, 27(7). https://doi.org/10.31083/rcm52887

Vancouver

Dimitriadou I, Samarinas M. Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?. Reviews in Cardiovascular Medicine. 2026;27(7). doi:10.31083/rcm52887

BibTeX
@article{Dimitriadou2026,
  author = {Dimitriadou, Ioanna and Samarinas, Michael},
  title = {Reframing Benign Prostatic Hyperplasia as a Cardiometabolic Condition: Should BPH Be Considered a Metabolic Disease?},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2026},
  volume = {27},
  number = {7},
  doi = {10.31083/rcm52887}
}
Kostenlos starten →